Panoraia Gourdoupi - Jul 20, 2022 Form 3 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role: Director
Signature: /s/ Panoraia Gourdoupi
Stock symbol: ADN
Transactions as of: Jul 20, 2022
Transactions value $: $0
Form type: 3
Date filed: 8/5/2022, 05:55 PM
Next filing: Sep 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ADN	Common Stock						379K	Jul 20, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ADN	Employee Stock Options (right to buy)							Jul 20, 2022	Common Stock	175K	$2.74	Direct	F2, F3
holding	ADN	Employee Stock Options (right to buy)							Jul 20, 2022	Common Stock	75K	$7.40	Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 175,000 restricted stock units ("RSUs") granted July 12, 2022, and 75,000 RSUs granted August 31, 2021, each representing a contingent right to receive common stock. Such RSUs were granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan"). RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% on each anniversary of their grant date over four years.
F2	Employee stock options (right to buy) ("Options") granted pursuant to the Plan.
F3	Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026.
F4	Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of August 31, 2025.